Meanwhile, RUNX2 expression was increased by increasing the expression of vascular endothelial growth factor, matrix metalloproteases (MMP2, MMP9, and MMP13), and bone sialoprotein (BSP) in breast cancer metastatic cells (Dowdy et al., 2010). Here, MMP13 is linked to breast cancer.